[
  {
    "date": "2023-12-30",
    "symbol": "UNCY",
    "period": "FY",
    "cash": 9701000,
    "prepaidexpenseandotherassetscurrent": 3698000,
    "assetscurrent": 13399000,
    "operatingleaserightofuseasset": 766000,
    "propertyplantandequipmentnet": 26000,
    "assets": 14191000,
    "accountspayablecurrent": 839000,
    "accruedliabilitiescurrent": 3234000,
    "warrantsandrightsoutstanding": 13134000,
    "operatingleaseliabilitycurrent": 327000,
    "liabilitiescurrent": 17534000,
    "operatingleaseliabilitynoncurrent": 466000,
    "liabilities": 18000000,
    "commonstockvalue": 35000,
    "additionalpaidincapital": 60697000,
    "retainedearningsaccumulateddeficit": -64541000,
    "stockholdersequity": -3809000,
    "liabilitiesandstockholdersequity": 14191000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 43649,
    "preferredstocksharesoutstanding": 43649,
    "preferredstocksharesissued": 43649,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 200000000,
    "commonstocksharesissued": 34756049,
    "commonstocksharesoutstanding": 34756049,
    "revenues": 675000,
    "researchanddevelopmentexpense": 12902000,
    "generalandadministrativeexpense": 8547000,
    "operatingexpenses": 21449000,
    "operatingincomeloss": -20774000,
    "investmentincomeinterest": 615000,
    "interestexpense": 82000,
    "fairvalueadjustmentofwarrants": 10303000,
    "othernonoperatingincomeexpense": -9770000,
    "netincomeloss": -30544000,
    "preferredstockdividendsandotheradjustments": 867000,
    "netincomelossavailabletocommonstockholdersbasic": -31411000,
    "earningspersharebasic": -1.28,
    "weightedaveragenumberofsharesoutstandingbasic": 24539309,
    "earningspersharediluted": -1.28,
    "weightedaveragenumberofdilutedsharesoutstanding": 24539309,
    "sharesoutstanding": 34756049,
    "stockissuedduringperiodvalueissuedforservices": 25407000,
    "stockissuedduringperiodsharesissuedforservices": 30190,
    "stockissuedduringperiodvaluedeemeddividendsonseriesa1preferredstock": -867000,
    "stockissuedduringperiodvalueconversionofunits": -26274000,
    "stockissuedduringperiodsharesconversionofunits": -30190,
    "stockissuedduringperiodvaluestockoptionsexercised": 27000,
    "stockissuedduringperiodsharesstockoptionsexercised": 8189,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationstockoptionsrequisiteserviceperiodrecognition": 1767000,
    "depreciation": 9000,
    "sharebasedcompensation": 1767000,
    "operatingleaserightofuseassetamortizationexpense": 275000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 1117000,
    "increasedecreaseinaccountspayableandaccruedliabilities": 1276000,
    "increasedecreaseinoperatingleaseliability": -252000,
    "netcashprovidedbyusedinoperatingactivities": -18283000,
    "paymentstoacquirepropertyplantandequipment": 12000,
    "netcashprovidedbyusedininvestingactivities": -12000,
    "financeleaseprincipalpayments": 496000,
    "proceedsfromissuanceofpreferredstockpreferencestockandwarrants": 30190000,
    "issuancecostsrelatedtoissuanceofseriesa1preferredstockandwarrants": -2153000,
    "netcashprovidedbyusedinfinancingactivities": 27541000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": 9246000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 9701000,
    "deferredpreclinicalchargesincludedinprepaidexpensesandothercurrentassets": 349000,
    "deferredinsurancechargesincludedinprepaidexpensesandothercurrentassets": 270000,
    "issuanceofseriesa2preferredstockandcommonstockuponconversionofseriesa1preferr": 26274000,
    "stockissued1": 867000,
    "fairvalueofwarrantsissuedinconnectionwiththeissuanceofpreferredstock": 2831000,
    "interestpaidnet": 24000,
    "risksanduncertaintiespolicytextblock": "Risks and Uncertainties",
    "prepaidexpensespolicytextblock": "<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify\"><b>Prepaid Expenses and Other Current Assets</b></p><p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify\">Prepaid expenses and other current assets representcosts incurred that benefit future periods. These costs are amortized over specific time periods based on the agreements.</p>",
    "patentcostspolicytextblock": "Patent Costs",
    "scheduleofcompanyhasrecordedstockbasedcompensationexpensetabletextblock": "The Company has recorded stock-based compensationexpense, which includes expense related to restricted stock units, allocated by functional cost as follows for the years ended December31, 2022 and 2023 (in thousands):",
    "liabilitiesfairvaluedisclosure": 13134000,
    "proceedsfromissuanceofwarrants": 2831000,
    "prepaidinsurance": 270000,
    "prepaidpreclinicalservices": 3103000,
    "otherprepaidexpensecurrent": 325000,
    "leaseholdimprovementsgross": 21000,
    "furnitureandfixturesgross": 21000,
    "propertyplantandequipmentgross": 42000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 16000,
    "accountspayabletradecurrent": 821000,
    "creditcardliability": 18000,
    "accruedsalariescurrent": 1917000,
    "accrueddrugdevelopmentcosts": 1034000,
    "otheraccruedliabilitiescurrent": 283000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 391000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 424000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 72000,
    "lesseeoperatingleaseliabilitypaymentsdue": 887000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 94000,
    "operatingleaseliability": 793000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnumberofsharesunderlyingoutstandingwarrantsoutstanding": 4784193,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsweightedaverageexercisepriceoutstanding": 6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsoutstandingweightedaverageremainingcontractualterms": "P2Y6M14D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsaggregateintrinsicvalueoutstanding": 36864000,
    "warrantsandrightsoutstandingmeasurementinput": 0.87,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnumberofsharesunderlyingoutstandingwarrantsissued": 160958167,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsweightedaverageexercisepricewarrantsissued": 0.64,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsweightedaverageremainingcontractualterminyearswarrantsissued": "P2Y1M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsaggregateintrinsicvaluewarrantsissued": 229069000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 8989487,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 0.75,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantedweightedaverageremainingcontractualterm": "P9Y7M9D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantedintrinsicvalue": 1072000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 21882,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 4.39,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 3.27,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 10302086,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P9Y4M2D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 1196000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisablenumber": 915187,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 3.02,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": "P7Y1M9D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": 96000,
    "allocatedsharebasedcompensationexpense": 847000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 1.04,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0435,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y6M",
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.0048,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.1224,
    "effectiveincometaxratereconciliationotheradjustments": -0.0708,
    "effectiveincometaxratereconciliationotherreconcilingitemspercent": 0.5,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 427000,
    "deferredtaxassetsoperatinglosscarryforwards": 5976000,
    "deferredtaxassetspropertyplantandequipment": 389000,
    "deferredtaxassetsinprocessresearchanddevelopment": 4106000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 439000,
    "deferredtaxassetsgross": 11337000,
    "deferredtaxassetsvaluationallowance": 11176000,
    "deferredtaxassetsnet": 161000,
    "deferredtaxliabilitiesother": 161000,
    "deferredincometaxliabilities": 161000,
    "unrecognizedtaxbenefits": 1027000,
    "unrecognizedtaxbenefitsincreasesresultingfrompriorperiodtaxpositions": 152000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 184000,
    "netincomelossavailabletocommonstockholdersdiluted": -31411000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 10302086,
    "entityincorporationdateofincorporation": "2016-08-18",
    "licensingrevenue": 700000,
    "paymentofvendernetrevenue": 2000000,
    "costofrevenue": 10000000,
    "vendorpayment": 2000000,
    "consecutiveyear": "P4Y",
    "totalpaymentsofcommercialsupplies": 10000000,
    "otherexpenses": 200000,
    "sublicenseincomepercentage": 0.4,
    "totalrelatedpayments": 2500000,
    "prepaidexpenseothernoncurrent": 2000000,
    "costsandexpensesrelatedparty": 1000000,
    "debtinstrumentfaceamount": 2200000,
    "prepaidexpenseandotherassets": 300000,
    "capitalleasesindemnificationagreementspayments": 3700000,
    "deferredrevenueupforntpayments": 700000,
    "deferredrevenuemilestonepayments": 3700000,
    "debtandequitysecuritiesandforeigncurrencytransactionpricechangeunrealizedgainlossoperatingbeforetax": 1000000,
    "transactionprice": 675000000,
    "lesseeoperatingleasetermofcontract": "P2Y",
    "lesseeoperatingleaseoptiontoextend": "three additional years",
    "operatingleasepayments": 331000000,
    "paymentsforrent": 354000000,
    "administrativefeesexpense": 6000000,
    "relatedpartytransactiontermsandmannerofsettlement": "June30, 2022",
    "definedcontributionplanemployerdiscretionarycontributionamount": 107000000,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 6,
    "warrantsandrightsoutstandingterm": "P5Y",
    "conversionofstocksharesconverted1": 736773,
    "conversionofstocksharesissued1": 184193,
    "designatedsharesofpreferredstock": 30190,
    "stockandwarrantsissuedduringperiodvaluepreferredstockandwarrants": 2800000,
    "preferredunitsofferingcosts": 2000000,
    "othercashequivalentsatcarryingvalue": 25400000,
    "annualratepercentage": 0.08,
    "preferredstockdividendratepercentage": 0.14,
    "paymentsofdividends": 900000,
    "dividendspayableamountpershare": 28.71,
    "preferredstockdividendspersharecashpaid": 1000,
    "extendedproductwarrantydescription": "the fair value of the Warrants was determined usinga Black Scholes model using parameters including (i) the exercise price of the warrant, (ii) the price of the underlying security, (iii)the time to expiration, or expected term, (iv) the expected volatility of the underlying security, (v) the risk-free rate, and (vi) estimatedprobability assumptions surrounding the achievement by the Company of technical milestones associated with regulatory and commercialprogress.",
    "adjustmentofwarrantsgrantedforservices": 13100000,
    "sharebasedgoodsandnonemployeeservicestransactionsharesapprovedforissuance": 12775996,
    "treasurystockcommonshares": 2815503,
    "fairvalueoptionchangesinfairvaluegainloss1": 5700000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnumberofsharesperiodincreasedecrease": 5000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P2Y10M24D",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 4000000,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangenumberofexercisableoptions": 1357,
    "unvestedoptionsamount": 4000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 27000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 382364,
    "compensationexpenseexcludingcostofgoodandservicesold": 1000000,
    "annualnetcashflowfromoperationspercentage": 0.75,
    "valuationallowancedeferredtaxassetchangeinamount": 3700000,
    "deferredtaxassetsoperatinglosscarryforwardsdomestic": 24700000,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 11600000,
    "taxableincomepercentage": 0.8,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 629000,
    "incometaxexpensebenefitpercentage": 0.5,
    "documenttype": "10-K",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentfinstmterrorcorrectionflag": "false",
    "entityinteractivedatacurrent": "Yes",
    "icfrauditorattestationflag": "false",
    "amendmentflag": "false",
    "documentperiodenddate": "2023-12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "UNICYCIVE THERAPEUTICS, INC.",
    "entitycentralindexkey": 1766140,
    "entityfilenumber": "001-40582",
    "entitytaxidentificationnumber": "81-3638692",
    "entityincorporationstatecountrycode": "DE",
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityshellcompany": "false",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "entityaddressaddressline1": "4300 El Camino Real",
    "entityaddressaddressline2": "Suite 210",
    "entityaddresscityortown": "Los Altos",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 94022,
    "cityareacode": "(650)",
    "localphonenumber": "351-4495",
    "security12btitle": "Common stock, par value $0.001 per share",
    "tradingsymbol": "UNCY",
    "securityexchangename": "NASDAQ",
    "auditorname": "Grassi & Co., CPAs, P.C",
    "auditorfirmid": 606,
    "auditorlocation": "Jericho, New York"
  },
  {
    "date": "2022-12-30",
    "symbol": "UNCY",
    "period": "FY",
    "cashandcashequivalentsatcarryingvalue": 455000,
    "otherprepaidexpensecurrent": 2189000,
    "assetscurrent": 2644000,
    "operatingleaserightofuseasset": 152000,
    "propertyplantandequipmentnet": 22000,
    "assets": 2818000,
    "accountspayablecurrent": 892000,
    "accruedliabilitiescurrent": 2237000,
    "operatingleaseliabilitycurrent": 155000,
    "liabilitiescurrent": 3284000,
    "liabilities": 3284000,
    "commonstockvalue": 15000,
    "additionalpaidincapital": 33516000,
    "retainedearningsaccumulateddeficit": -33997000,
    "stockholdersequity": -33997000,
    "liabilitiesandstockholdersequity": 2818000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 200000000,
    "commonstocksharesissued": 15231655,
    "commonstocksharesoutstanding": 15231655,
    "revenues": 951000,
    "researchanddevelopmentexpense": 12436000,
    "generalandadministrativeexpense": 6567000,
    "operatingexpenses": 19003000,
    "operatingincomeloss": -18052000,
    "interestexpense": 6000,
    "nonoperatingincomeexpense": -6000,
    "netincomeloss": -18058000,
    "earningspersharebasic": -1.2,
    "weightedaveragenumberofsharesoutstandingbasic": 15057049,
    "earningspersharediluted": -1.2,
    "weightedaveragenumberofdilutedsharesoutstanding": 15057049,
    "sharesoutstanding": 15231655,
    "stockissuedduringperiodvaluenewissues": 11000,
    "stockissuedduringperiodsharesissuedforservices": 108032,
    "stockissuedduringperiodvalueother": 21000,
    "issuanceofcommonstockinsettlementofaccountspayable": 33500,
    "stockissuedduringperiodsharesrestrictedstockawardgross": 26738,
    "stockissuedduringperiodvaluestockoptionsexercised": 29000,
    "stockissuedduringperiodsharesstockoptionsexercised": 66851,
    "sharebasedcompensation": 1047000,
    "depreciation": 7000,
    "othernoncashexpense": 21000,
    "allocatedsharebasedcompensationexpense": 1047000,
    "operatingleaserightofuseassetamortizationexpense": 154000,
    "increasedecreaseinothercurrentassets": -62000,
    "increasedecreaseinaccountspayableandaccruedliabilities": 1267000,
    "increasedecreaseinoperatingleaseliability": -151000,
    "netcashprovidedbyusedinoperatingactivities": -15651000,
    "paymentstoacquirepropertyplantandequipment": 2000,
    "netcashprovidedbyusedininvestingactivities": -2000,
    "issuanceofcommonstockforcashnetofissuancecosts": -11000,
    "financeleaseprincipalpayments": 482000,
    "netcashprovidedbyusedinfinancingactivities": -471000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -16124000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 455000,
    "deferredpreclinicalchargesincludedinprepaidexpensesandothercurrentassets": 420000,
    "deferredinsurancechargesincludedinprepaidexpensesandothercurrentassets": 240000,
    "significantagreementspolicies": "3. Significant Agreements ",
    "balancesheetcomponentstextblock": "5. Balance Sheet Components ",
    "risksanduncertaintiespolicytextblock": "Risks and Uncertainties ",
    "prepaidexpensespolicytextblock": "Prepaid Expenses ",
    "patentcostspolicytextblock": "Patent Costs ",
    "commonstockvaluationspolicytextblock": "Common Stock Valuations ",
    "comprehensivelosspolicytextblock": "Comprehensive Loss ",
    "prepaidinsurance": 476000,
    "prepaidpreclinicalservices": 1554000,
    "otherassetsmiscellaneouscurrent": 159000,
    "inventorynet": 2189000,
    "leaseholdimprovementsgross": 15000,
    "furnitureandfixturesgross": 14000,
    "propertyplantandequipmentgross": 29000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 7000,
    "accountspayabletradecurrent": 846000,
    "creditcardliability": 46000,
    "accountspayablecurrentandnoncurrent": 892000,
    "accruedlaborcosts": 1487000,
    "accrueddrugdevelopmentcosts": 228000,
    "otheraccruedliabilitiescurrent": 522000,
    "accruedreclamationcostscurrent": 2237000,
    "lessoroperatingleasepaymentstobereceivedrollingyearthree": 161000,
    "lessimputedinterestratepresentvaluediscount": 6000,
    "presentvalueofleaseliability": -155000,
    "lesscurrentportion": -155000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingnumber": 4784193,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": 4.54,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": 4.54,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 1342670,
    "weightedaverageremainingcontractualtermoutstanding": 8.66,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisablenumber": 683661,
    "weightedexercisepriceoptionvestedandexercisable": 3.14,
    "share-basedweightedaverageremainingcontractualtermsharesvestedandexercisable": 7.87,
    "aggregateintrinsicvalueoptionsvestedandexercisable": 52000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 324000,
    "share-basedweightedaverageexercisepriceoptionsoptionsexercised": 0.75,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedoptionsforfeitednumberofshares": 125547,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice": 3.05,
    "numberofsharesunderlyingoutstandingoptionsoptionsexercised": 66851,
    "weightedaverageexercisepriceoptionsexercised": 0.45,
    "weightedaverageexercisespriceoutstandingending": 2.75,
    "sharebasedcompensationarrangementbysharebasedpaymentsawardoptionsexercisableweightedaverageremainingcontractualterm2": 8.47,
    "aggregateintrinsicvalueoutstandingending": 52000,
    "researchanddevelopment": 664000,
    "sellinggeneralandadministrativeexpense": 383000,
    "employeebenefitsandsharebasedcompensation": 1047000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 1.05,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0396,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 6.25,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.0239,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.2404,
    "others": 0.006500000000000001,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 373000,
    "deferredtaxassetsoperatinglosscarryforwards": 4156000,
    "depreciationdepletionandamortization": 428000,
    "deferredtaxliabilitiesdeferredexpensecapitalizedresearchanddevelopmentcosts": 2221000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 260000,
    "deferredtaxassetsgross": 7438000,
    "deferredtaxassetsvaluationallowance": 7438000,
    "allowancefordoubtfulaccountsreceivable": 690000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 589000,
    "netincomelossavailabletocommonstockholdersbasic": -18058000,
    "optionstopurchasecommonstock": 1342670,
    "warrantstopurchasecommonstock": 4784193,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 6126863,
    "licensingrevenue": 1000000,
    "accmulateddeficit": 34000000,
    "purchaseagreement": 30000000,
    "aggregateamount": 50000000,
    "netproceeds": 28100000,
    "financialterm": "one year",
    "incometaxlargestamount": 0.5,
    "otherresearchanddevelopmentexpense": 1000000,
    "otherexpenses": 4.5,
    "purchaseagreementdescription": "The Company is also requiredto pay Spectrum 40% of all of the Company’s sublicense income for any sublicense granted to certain sublicensees during the first12 months after the Closing Date (as that term is defined in the Renazorb Purchase Agreement) and 20% of all other sublicense income.The Company’s payment obligations to Spectrum will expire on the twentieth (20th) anniversary of the Closing Date ofthe Renazorb Purchase Agreement.",
    "concentrationriskpercentage": 0.2,
    "costsandexpensesrelatedparty": 700000,
    "prepaidexpenseothernoncurrent": 400000,
    "interestexpenseother": 400000,
    "budgetforservices": 2700000,
    "proceedsfromlicensefeesreceived": 1000000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 152000,
    "operatingleasepaymentsuse": 170000,
    "financeleaseliabilitypaymentsdue": 155000,
    "leaseandrentalexpense": 173000,
    "conversionpricepercentage": 0.7000000000000001,
    "professionalandcontractservicesexpense": 6000,
    "noninterestexpenseinvestmentadvisoryfees": 100000,
    "definedcontributionplancostrecognized": 60000,
    "saleofstockpricepershare": 1000,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 6,
    "warrantsandrightsoutstandingterm": 5,
    "excessstocksharesissued": 190000,
    "conversionofstocksharesconverted1": 736773,
    "conversionofstocksharesissued1": 184193,
    "treasurystockcommonshares": 389676,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnumberofsharesperiodincreasedecrease": 1100000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 2.3,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangenumberofexercisableoptions": 9546,
    "unvestedoptionsamount": 31000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 29000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 374168,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 5000,
    "effectiveincometaxratereconciliationdeductions": 0.21,
    "valuationallowancedeferredtaxassetchangeinamount": 4400000,
    "effectiveincometaxratereconciliationtaxsettlementsother": 0.154,
    "futuretaxableincome": 13100000,
    "taxableincomepercentage": 0.8,
    "incometaxreconciliationnondeductibleexpenseresearchanddevelopment": 444000,
    "reducefuturetaxableincome": 245000,
    "effectiveincometaxratereconciliationrepatriationforeignearningsjobscreationactof2004": 1,
    "effectiveincometaxratereconciliationsharebasedcompensationexcesstaxbenefitpercent": 0.5,
    "unrecognizedtaxbenefitsthatwouldimpacteffectivetaxrate": 690000,
    "aggregatepercentage": 0.75,
    "entityregistrantname": "UNICYCIVE THERAPEUTICS,INC.",
    "tradingsymbol": "UNCY",
    "documenttype": "10-K",
    "currentfiscalyearenddate": "December 31",
    "amendmentflag": "false",
    "entitycentralindexkey": 1766140,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated Filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "December 31, 2022",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityshellcompany": "No",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-40582",
    "entityincorporationstatecountrycode": "Delaware",
    "entitytaxidentificationnumber": "81-3638692",
    "entityaddressaddressline1": "4300 El Camino Real",
    "entityaddressaddressline2": "Suite 210",
    "entityaddresscityortown": "Los Altos",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 94022,
    "cityareacode": "(650)",
    "localphonenumber": "351-4495",
    "security12btitle": "Common stock, par value $0.001 per share",
    "securityexchangename": "Nasdaq",
    "entityinteractivedatacurrent": "Yes",
    "auditorfirmid": 199,
    "auditorname": "Mayer Hoffman McCann P.C.",
    "auditorlocation": "San Diego, California"
  },
  {
    "date": "2021-12-30",
    "symbol": "UNCY",
    "period": "FY",
    "cashandcashequivalentsatcarryingvalue": 16579000,
    "prepaidexpenseandotherassetscurrent": 1832000,
    "assetscurrent": 18411000,
    "operatingleaserightofuseasset": 305000,
    "propertyplantandequipmentnet": 28000,
    "assets": 18744000,
    "accountspayablecurrent": 742000,
    "accruedliabilitiescurrentandnoncurrent": 1212000,
    "operatingleaseliabilitycurrent": 151000,
    "liabilitiescurrent": 2105000,
    "operatingleaseliabilitynoncurrent": 155000,
    "liabilities": 2260000,
    "commonstockvalue": 15000,
    "additionalpaidincapital": 32408000,
    "retainedearningsaccumulateddeficit": -15939000,
    "stockholdersequity": -15939000,
    "liabilitiesandstockholdersequity": 18744000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 200000000,
    "commonstocksharesissued": 14996534,
    "commonstocksharesoutstanding": 14996534,
    "researchanddevelopmentexpense": 6080000,
    "generalandadministrativeexpense": 2897000,
    "operatingexpenses": 8977000,
    "operatingincomeloss": -8977000,
    "interestexpense": 628000,
    "lossondebtconversion": -431000,
    "gainslossesonextinguishmentofdebt": 19000,
    "nonoperatingincomeexpense": -1040000,
    "netincomeloss": -10017000,
    "earningspersharebasic": -0.86,
    "weightedaveragenumberofsharesoutstandingbasic": 11675750,
    "sharesoutstanding": 14996534,
    "profitloss": -10017000,
    "stockissuedduringperiodnetproceedsfrominitialpublicoffering": 22271000,
    "stockissuedduringperiodsharesother": 5000000,
    "stockissuedduringperiodvalueconversionofconvertiblesecurities": 3685000,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": 736773,
    "stockissuedduringperiodvaluestockoptionsexercised": 59000,
    "stockissuedduringperiodsharesstockoptionsexercised": 307317,
    "stockissuedduringperiodvalueissuedforservices": 2191000,
    "stockissuedduringperiodsharesissuedforservices": 438374,
    "stockissuedduringperiodvaluesharebasedcompensation": 966000,
    "depreciationnonproduction": 1000,
    "rdexpenseforissuanceofcommonstockforantidilutionclause": 2191000,
    "allocatedsharebasedcompensationexpense": 966000,
    "amortizationofdebtdiscountpremium": 488000,
    "operatingleaserightofuseassetamortizationexpense": 12000,
    "paidinkindinterest": 139000,
    "gainonextinguishmentofdebt": 19000,
    "increasedecreaseindeferredrevenue": 146000,
    "lossondebtconversions": 431000,
    "increasedecreaseinprepaidexpensesother": 1325000,
    "increasedecreaseinaccountspayableandaccruedliabilities": 1241000,
    "increasedecreaseinoperatingleaseliability": -12000,
    "relatedpartyservicefeepayable": 9000,
    "netcashprovidedbyusedinoperatingactivities": -5767000,
    "purchasesofpropertyplantandequipment": -29000,
    "netcashprovidedbyusedininvestingactivities": -29000,
    "proceedsfromissuanceinitialpublicoffering": 22271000,
    "proceedsfromshorttermdebt": 248000,
    "proceedsfromissuanceofotherlongtermdebt": 1098000,
    "repaymentsofothershorttermdebt": 1361000,
    "proceedsfromstockoptionsexercised": 119000,
    "netcashprovidedbyusedinfinancingactivities": 22375000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 16579000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 16579000,
    "deferredpreclinicalchargesincludedinprepaidexpensesandothercurrentassets": -503000,
    "significantagreementstextblock": "3. SignificantAgreements ",
    "balancesheetcomponentstextblock": "4. BalanceSheet Components ",
    "risksanduncertaintiespolicytextblock": "Risksand Uncertainties ",
    "prepaidexpensepolicytextblock": "PrepaidExpenses ",
    "patentcostspolicytextblock": "PatentCosts ",
    "commonstockvaluationspolicytextblock": "CommonStock Valuations ",
    "scheduleofprepaidexpensesandothercurrentassetstabletextblock": "            As of      As of             December 31,      December 31,             2020      2021       Prepaid directors and officers    liability insurance premiums     $        -      $821       Prepaid preclinical services      -       885       Other      4       126       Total     $4      $1,832    ",
    "prepaidinsurance": 821000,
    "prepaidpreclinicalservices": 885000,
    "otherprepaidexpensecurrent": 126000,
    "total": 1832000,
    "leaseholdimprovementsgross": 15000,
    "furnitureandfixturesgross": 14000,
    "propertyplantandequipmentgross": 29000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 1000,
    "accountspayabletradecurrentandnoncurrent": 713000,
    "creditcardliability": 29000,
    "accountspayablecurrentandnoncurrent": 742000,
    "accruedlaborcosts1": 691000,
    "accrueddrugdevelopmentcosts": 369000,
    "otheraccruedliabilitiescurrent": 152000,
    "accruedreclamationcostscurrent": 1212000,
    "lessoroperatingleasepaymentstobereceivedrollingyeartwo": 170000,
    "lessoroperatingleasepaymentstobereceivedrollingyearthree": 161000,
    "lessoroperatingleasepaymentstobereceived": 331000,
    "lessimputedinterestratepresentvaluediscount": -25000,
    "presentvalueofleaseliability": 306000,
    "lesscurrentportion": -151000,
    "longtermportion": 155000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingnumber": 4784193,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsgranted": 4784193,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": 4.54,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 1211068,
    "weightedaverageexercisespricesoutstanding": 3.19,
    "weightedaverageremainingcontractualtermoutstanding": 8.28,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 321,
    "sharebasedcompensationarrangementbysharebasedpaymentsawardoptionsexercisableweightedaverageremainingcontractualterm2": 8.66,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 760245,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 3.82,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 27907,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 3.27,
    "numberofsharesunderlyingoutstandingoptionsoptionsexercised": 307317,
    "share-basedcompensationweightedaverageexercisepriceoptionsoptionsexercised": 0.19,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisablenumber": 301862,
    "share-basedcompensationweightedaverageexercisepriceoptionssharesvestedandexercisable": 3.19,
    "share-basedweightedaverageremainingcontractualtermsharesvestedandexercisable": 7.94,
    "aggregateintrinsicsvaluesharesvestedandexercisable": 182,
    "researchanddevelopment": 721000,
    "sellinggeneralandadministrativeexpense": 245000,
    "employeebenefitsandsharebasedcompensation": 966000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 1.05,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0134,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 6.25,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.1627,
    "interestonconvertiblenotes": -0.0222,
    "others": -0.025099999999999997,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 226000,
    "deferredtaxassetsoperatinglosscarryforwards": 2257000,
    "depreciation": 468000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 135000,
    "deferredtaxassetsgross": 3086000,
    "deferredtaxassetsvaluationallowance": 3086000,
    "allowancefordoubtfulaccountsreceivable": 101000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 72000,
    "optionstopurchasecommonstock": 1211068,
    "paymentsforrepurchaseofwarrants": 4784193000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 5995261,
    "accmulateddeficit": 15900000,
    "cash": 16.6,
    "financialterm": "one year",
    "deferredcosttotal": 900000,
    "incometaxlargestamount": 0.5,
    "purchaseagreementdescription": "The Company is also required to pay Spectrum 40% of all of the Company’s sublicenseincome for any sublicense granted to certain sublicensees during the first 12 months after the Closing Date (as that term is definedin the Renazorb Purchase Agreement) and 20% of all other sublicense income. The Company’s payment obligations to Spectrum willexpire on the twentieth (20th) anniversary of the Closing Date of the Renazorb Purchase Agreement.",
    "areaofland": 2367,
    "presentvalueoflease": 318000,
    "lesseeoperatingleasediscountrate": 0.08,
    "rightofuseassets": 12000,
    "financeleaserightofuseassetamortization": 305000,
    "operatingleasepaymentsuse": 14000,
    "financeleaseliabilitypaymentsdue": 306000,
    "leaseandrentalexpense": 14000,
    "accruedinterest": 431000,
    "receivedadvancesfromthestockholder": 248000,
    "repaidamountsowedtothestockholder": 1.4,
    "definedcontributionplanemployermatchingcontributionpercent": 1,
    "participantscontributionpercentage": 1,
    "employeeseligiblecompensationpercentage": 0.04,
    "warrantsandrightsoutstandingterm": 5,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 6,
    "conversionofstocksharesconverted1": 736773,
    "conversionofstocksharesissued1": 184193,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodtotalfairvalue": 2100000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardcompensationcost1": 2000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 2.4,
    "restrictedstockexpense": 54000,
    "valuationallowancedeferredtaxassetchangeinamount": 1600000,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 900,
    "futuretaxableincome": 100000,
    "netoperatinglossesexpiredescription": "Federal net operating losses generated prior to 2018 and all state net operatinglosses generated expire in varying amounts beginning in 2037. These net operating losses, generated after 2017, do not expire and willbe able to offset 80% of taxable income generated in the future.",
    "amountofbenefit": 0.5,
    "unrecognizedtaxbenefitsincometaxpenaltiesandinterestaccrued": 101000,
    "entityregistrantname": "UNICYCIVETHERAPEUTICS, INC.",
    "tradingsymbol": "UNCY",
    "documenttype": "10-K",
    "currentfiscalyearenddate": "December 31",
    "amendmentflag": "false",
    "entitycentralindexkey": 1766140,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated Filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "December 31, 2021",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityshellcompany": "No",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-40582",
    "entityincorporationstatecountrycode": "Delaware",
    "entitytaxidentificationnumber": "81-3638692",
    "entityaddressaddressline1": "4300 El Camino Real",
    "entityaddressaddressline2": "Suite 210",
    "entityaddresscityortown": "Los Altos",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 94022,
    "cityareacode": "(650)",
    "localphonenumber": "351-4495",
    "security12btitle": "Common stock, par value $0.001 per share",
    "securityexchangename": "Nasdaq",
    "entityinteractivedatacurrent": "Yes",
    "auditorfirmid": 199,
    "auditorname": "Mayer Hoffman McCann P.C.",
    "auditorlocation": "San Diego, California"
  }
]